Medication adherence in the 12-month follow-up period after the Support, Educate, Empower (SEE) glaucoma coaching program

Document Type

Conference Proceeding

Publication Date

6-1-2022

Publication Title

Invest Ophthalmol Vis Sci

Keywords

adult, clinical article, conference abstract, controlled study, counseling, female, follow up, glaucoma, human, human tissue, laser, male, medication compliance, Michigan, New York, pilot study

Abstract

Purpose : Motivational Interviewing (MI) has improved medication adherence rates for patients with chronic illnesses. The Support, Educate, Empower (SEE) program, a 7-month MI-based personalized glaucoma coaching program, has previously shown to improve medication adherence by 21-percentage points in a sample of non-adherent glaucoma patients. The goal of this study was to assess adherence in the 12-months following the conclusion of the SEE program intervention. Methods : Glaucoma patients ≥40 years, taking ≥1 medication, self-reporting poor medication adherence were recruited from the University of Michigan for the SEE pilot study. Participants' medication adherence rates were monitored electronically (AdhereTech, New York, NY) during a 3-month pre-intervention phase (pre-counselling adherence), 7-month intervention phase while they received personalized coaching sessions (counselling adherence), and for an additional 12-months following the conclusion of their coaching sessions (post-counselling adherence). Adherence was summarized with descriptive statistics and compared using paired t-tests. Results : Medication adherence data were available for 39 participants. Post-counselling adherence rates were censored for 18 participants (56%); 3 participants received glaucoma laser or incisional surgery, 3 had changes made to their glaucoma medication regiment, and 12 stopped using their electronic medication monitors before the full 12- month follow-up period. Average follow-up was 284 days (standard deviation, SD=110, range=41 to 365). The average post-counselling adherence was 66.5% (SD=22.5%), significantly less than the average counselling adherence rate of 81.3% (SD=17.6%, p<0.0001) but significantly more than pre-counselling adherence rate of 59.9% (SD=18.5%, p=0.04). The decrease in adherence post-counseling was mostly observed in the first 4 months (mean decrease=17.4%, SD=19.5%, p<0.0001). Conclusions : Medication adherence rates significantly decreased among SEE program participants in the 12 months following their last counselling session, although they were still significantly higher than pre-counselling adherence rates. These results suggest that glaucoma patients may need additional counselling sessions to see continued benefit from the program. We suggest that patients should be seen every 3-month for a ?booster? counselling session.

Volume

63

Issue

7

First Page

1646-A0141

Find It @ Sladen

Share

COinS